Thomas G.

Thomas G. currently serves as Vice President of Global Healthcare at Degroof Petercam since November 2023. Prior experience includes freelance work as a PharmD from June 2023 to January 2024, and a role as Director of Investor Relations at OSE Immunotherapeutics from June 2021 to May 2023. Thomas held positions as a Biotech Equity Analyst at Degroof Petercam from October 2019 to June 2021 and as a Biotech/Medtech Equity Analyst at Kepler Cheuvreux from September 2016 to September 2019. Additional experience includes working as an M&A Analyst in Healthcare at Societe Generale Corporate and Investment Banking from March 2015 to September 2016, and as an Equity Research Analyst at Natixis from June 2012 to June 2014. Thomas began the career as an Assistant Brand Manager at Second Stage Pharma from December 2010 to April 2011. Academic qualifications include an MSc in Management with a focus on Healthcare Systems Management and Corporate Finance from ESSEC Business School and a Pharmaceutical degree from Université de Rouen, complemented by studies at the University of Navarra.